Picture of Verve Therapeutics logo

VERV — Verve Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Verve Therapeutics Q3 EPS USD -0.59

Nov 05 (Reuters) - Verve Therapeutics Q3 net income USD -50.133 million.
* Q3 collaboration revenue USD 6.865 million

Recent news on Verve Therapeutics

See all news